During a public policy forum held Monday night at St Philip’s Princess Margaret Secondary School, Barbadian Prime Minister Mia Mottley announced that the island nation’s Ministry of Health is currently conducting feasibility assessments for a national colorectal cancer screening program, a long-missing public health initiative that local medical leaders have repeatedly called for. The discussion was sparked by Dr. Marek Stobinski, a recently relocated gastroenterologist who practices at Bayview Hospital and a local private clinic, who used the forum platform to push for urgent investment in early detection infrastructure for colorectal cancer.
After moving to Barbados, Dr. Stobinski told attendees he conducted a search to identify existing preventive public health programs where he could contribute his expertise, only to find no national colorectal screening framework currently exists. “I started looking for prophylactic programmes, and I cannot find any in Barbados, so I’ll be the biggest advocate for a colorectal cancer screening programme in Barbados,” he stated.
The gastroenterologist emphasized that colorectal cancer is no longer an illness confined to older populations, sharing a recent case of an otherwise healthy 40-year-old patient he diagnosed with the disease to illustrate the gap in preventive care. “I had my concerns that we need to do something before the cancer spread, and it will be too late for treatment,” he added.
Public health data confirms that early detection drastically improves outcomes for colorectal cancer patients: precancerous growths called polyps can be removed quickly before they develop into malignant tumors. Dr. Stobinski noted that removing early-stage polyps takes as little as 15 minutes in most cases, a simple outpatient procedure that prevents cancer from developing and spreading to other parts of the body.
Prime Minister Mottley echoed the physician’s call for urgent action, sharing a personal and cultural touchstone to underscore the need for widespread screening. She pointed to the 1999 death of beloved Barbadian and West Indies cricket legend Malcolm Marshall, who passed away from colorectal cancer at just 41 years old. “How old was Malcolm Marshall when he died? You think he would’ve died if he had the screening and they did the surgery?” she asked attendees.
Mottley also shared that she undergoes routine colonoscopies herself, explaining that timely polyp removal cuts the risk of developing colorectal cancer dramatically. “If you find the polyps and remove them, you do what? Minimise. Doctors tell me don’t ever use the word extinguish, but you minimise the chance of cancer to almost zero,” she said.
Dr. Sonia Browne, the Member of Parliament for St Philip North and a practicing general practitioner, added another key consideration to the discussion: while launching a screening program is critical, ensuring consistent follow-up care for patients identified as high-risk remains a major systemic challenge. “The headache seems to be the follow-up when you do have, you found the patient,” she noted. Even so, she stressed that investing in upfront screening and early intervention is far more cost-effective than covering treatment for late-stage, advanced cancer that could have been prevented.
Alongside the announcement about colorectal screening, Mottley revealed that the Barbadian government is also evaluating the potential introduction of GLP-1 receptor agonists, the widely used class of anti-obesity medications that includes semaglutide, liraglutide, and tirzepatide. The government is currently weighing whether the long-term public health benefits of expanding access to these drugs outweigh their higher initial costs, the prime minister explained.
Mottley argued that the government must avoid short-sighted cost-cutting that leads to higher health spending down the line, noting that obesity is linked to a range of serious, costly complications including amputations and kidney failure that require ongoing dialysis. “We’re not going to end up being penny wise and pound foolish, but we will be strategic in our deployment of resources to be able to help people help themselves and to save lives,” she said.
The World Health Organization recently issued landmark clinical guidelines that conditionally recommend GLP-1 receptor agonists for long-term weight management in adults living with obesity. The global health body stresses that these medications must always be paired with lifestyle interventions including balanced diets and regular physical activity to deliver sustained benefits. Clinical trials confirm GLP-1 drugs help most patients lose 10 to 20 percent of their starting body weight by reducing appetite and persistent food cravings. However, the medications are associated with common mild to moderate gastrointestinal side effects, and most patients regain significant weight if they stop taking the drug.
At the close of the forum, Mottley reaffirmed the government’s commitment to expanding preventive screening for three of the most common high-burden cancers: breast, prostate, and colorectal. “Because if you get in early, you do what? Give yourself a credible chance of recovery and full life again,” she said.